ESBRIET

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: 3da7c5a1b368c5cb
Drug Approval Canada Name: ESBRIET
Product Name: ESBRIET
Status: Marketed
Status Date: 2017-07-26
Original Market Date: 2017-07-26
Din: 02464500
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 48:02.00
Atc Original: L04AX05 PIRFENIDONE
Atc Name: l 04 ax 05
Aig Number: 0153328003
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

PIRFENIDONE

801 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

3da7c5a1b368c5cb

Type

Standard